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Sepsis is a systemic, deleterious host response to infection leading to severe sepsis and septic shock. Severe sepsis and septic shock are major health-care problems, affecting millions of people around the world each year, killing one in four (and often more), and increasing in incidence.\[[@ref1][@ref2][@ref3][@ref4][@ref5]\] According to the World Health Organization estimates, sepsis accounts for 60%--80% of lost lives per year in childhood.\[[@ref6]\] Similar to polytrauma, acute myocardial infarction or stroke, the speed and appropriateness of therapy administered in the initial hours after severe sepsis develops are likely to influence outcome.

The recommendations of surviving sepsis campaign (SSC) guidelines are intended to provide guidance for the clinician caring for a patient with severe sepsis or septic shock. The outcome improvement can be made through education and process change by SSC guidelines for those caring for severe sepsis patients in the intensive care unit (ICU) and non-ICU settings across the spectrum of acute care.\[[@ref7]\]

In 2004, the SSC endorsed the early goal-directed therapy for the management of severe sepsis and septic shock. It was aimed at obtaining a 25% reduction in mortality over the following 5 years in patients with septic shock worldwide.\[[@ref8][@ref9]\] These guidelines have been summarized by the SSC in sepsis bundles, which represent key elements of care regarding the diagnosis and treatment of patients with septic shock.\[[@ref10]\]

The Institute for the SSC provides in 2004 two bundles for septic shock patients: The 6-h resuscitation bundle and the 24-h management bundle (<http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis>). Many studies showed that implementation of 6-h resuscitation and 24-h management sepsis bundles decreased crude in-hospital or day 28 mortality, reduced the length of stay (in hospital/ICU), reduced the cost of care and improved the patients\' quality of life.\[[@ref11][@ref12][@ref13][@ref14]\] The beneficial effect of sepsis bundles on mortality has been confirmed in a meta-analysis, including 50 studies published from 2004 to 2014 showing a significant decrease in mortality in the majority of studies with an overall odds ratio of 0.66 (95% confidence interval: 0.61--0.72).\[[@ref15]\]

Several studies also showed that the extent of the decrease in mortality could depend on the number of bundle interventions completed.\[[@ref12][@ref13][@ref16][@ref17]\]

Over the last 10 years or so, the epidemiology of pediatric severe sepsis has been dramatically affected by the introduction of effective vaccines against what were the most common causes of community-acquired sepsis in children.

It is becoming increasingly common that patients admitted to pediatric intensive care with severe sepsis in this current postvaccine era are those with extreme prematurity, preexisting comorbidities, or who are immunocompromised in some way.\[[@ref18]\]

Due to this change in epidemiology, understanding the pathophysiology of pediatric sepsis has proven more difficult, and rational interventions to interrupt the "sepsis cascade" have proven less effective than predicted, probably because these children are not previously healthy with community-acquired sepsis, but are a heterogeneous mixture of patients with varied pathologies. It is likely that more generic measures or "bundles of care," such as are recommended in tools such as the SSC, will prove beneficial in pediatric practice, as they have been shown to be in adult practice.\[[@ref7]\]

The 6-h sepsis resuscitation bundle in many studies has been associated with decreased mortality in patients of severe sepsis and septic shock. However, the application of these guidelines for the management of severe sepsis and septic shock in pediatric patients is still poor with little data available from studies on pediatric population in India. Very few studies have been done so far to assess the impact of 6-h sepsis bundle on the outcome of pediatric patients with severe sepsis and septic shock world over including India till now.

Aim and Objective {#sec2-1}
-----------------

The aims and objectives of the study are to evaluate whether 6-h sepsis bundle component compliance (complete vs. incomplete) makes any significant difference to the outcome in pediatric patients with severe sepsis and septic shock. The outcome being measured in terms of mortality and surrogates of the severity of illness.

M[ETHODOLOGY]{.smallcaps} {#sec1-2}
=========================

The study was conducted in a tertiary care hospital in Delhi between May 2015 and June 2017. It was a prospective observational study. Patients from 1 month to 13 years of age (excluding neonates) with severe sepsis and septic shock were included in the study. Prior approval was obtained from hospital\'s Research Ethics Committee. Informed consent from the parents of eligible children was obtained. Patient\'s age, sex, admission date, vitals, fluid resuscitation, time of antibiotics given, maximum dose and duration of inotropes, lactate levels at admission and after 6 h, blood cultures, and blood gas were recorded after admission and compliance to each of the components of 6 h sepsis bundle was documented in a predesigned pro forma. Variables required for calculating predicted mortality were recorded at admission and entered into an online pediatric index of mortality-2 (PIM-2) score calculator which gives the likelihood of mortality as percentage.\[[@ref19]\] All the patients were followed during the entire duration of their hospital stay, and the outcome was recorded as mortality or discharge. Patients were divided into two groups based on 6-h sepsis bundle component compliance (complete vs. incomplete). Those fulfilling all the components of 6-h sepsis bundle were taken as compliant while failure to fulfill even a single component rendered them noncompliant. Both groups (compliant vs. noncompliant) were compared with outcome being measured in terms of mortality or discharge, dose, and duration of inotropes used, length of hospital stay, lactate levels, and time taken for perfusion to improve.

Statistical analysis {#sec2-2}
--------------------

Categorical variables were presented as number and percentage (%), and continuous variables were presented as mean ± standard deviation and median. Normality of data was tested by Kolmogorov--Smirnov test. If the normality was rejected then nonparametric test was used.

Statistical tests were applied as follows:

Quantitative variables were compared using Unpaired *t*-test/Mann--Whitney test (when the data sets were not normally distributed) between the two groups and Kruskal--Wallis tests was used for comparison between two groups. Qualitative variables were correlated using Chi-square test. *P* \< 0.05 was considered statistically significant. The data were entered into MS Excel spreadsheet and analysis was done using IBM SPSS Statistics for windows, Version 21.0 (IBM Corp., Armonk, NY: USA).

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

A total of 116 patients with a diagnosis of severe sepsis and septic shock were included during the study. Out of which 62.93% were males as compared to 37.07% females. Ninety patients (77.59%) were compliant while 26 (22.41%) were noncompliant with the 6-h sepsis bundle. Of 90 patients, 40 died (44.44%) in the compliant group as compared to 5 out of 26 (19.23%) in the noncompliant group, and the difference in mortality was statistically significant *P* = 0.020. No significant differences were found in the compliant and noncompliant groups regarding the age, dose, and duration of inotropes (dopamine/dobutamine/adrenaline), total hospital stay and time taken for perfusion to improve \[[Table 1](#T1){ref-type="table"}\].

###### 

Comparison of basic charecteristics between compliant and noncompliant groups

![](IJCCM-22-852-g001)

Based on the predicted mortality, patients were divided into three subgroups (predicted mortality \<30%, 30%--50%, \>50%). In \>50% predicted mortality subgroup, 18 out of 21 (85.71%) died in compliant group, while 2 out of 2 (100%) mortality was observed in noncompliant group (*P* = 1). In \<30% predicted mortality subgroup 12.5% died in the noncompliant group as compared to 20% in the compliant group (*P* = 0.533). Although overall mortality was significantly higher in the compliant group (44.44% vs. 19.23%, *P* = 0.02), the difference failed to reach significance in any of the predicted mortality subgroups because of less number of patients available in the noncompliant group \[[Table 2](#T2){ref-type="table"}\].

###### 

Outcome in different subgroups of predicted mortality among compliant and non-compliant

![](IJCCM-22-852-g002)

The initial blood lactate levels (mean and Standard deviation) were significantly higher (6.97 ± 3.54 vs. 2.59 ± 2.39, *P* \< 0.001) in the compliant group and the remeasured lactate within 6 h were still higher in the compliant group (3.34 ± 2.97 vs. 0.52 ± 0.33, *P* \< 0.019) \[[Table 3](#T3){ref-type="table"}\].

###### 

Blood lactate levels in compliant and non-compliant groups
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Blood lactate levels (mean and Standard deviation) at admission (9.26 ± 3.54 vs. 4.08 ± 1.99) and remeasured lactate after sepsis bundle intervention (5.34 ± 3.23 vs. 1.59 ± 1.19) were significantly higher in those who died as compared to the survivors, *P* \< 0.0001 \[[Table 4](#T4){ref-type="table"}\].

###### 

Relationship of Blood lactate levels with outcome
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Higher lactate levels were observed to be related to higher predicted mortality by PIM-2 score. Patients with more than 50% predicted mortality in compliant group had higher initial (mean and Standard deviation, 10.27 ± 3.51) as well as post sepsis bundle intervention lactates (mean and Standard deviation, 6.28 ± 3.65) *P* \< 0.0001. In noncompliant group, the difference in initial and post-interventional lactate levels was not significant, *P* = 0.206 \[[Table 5](#T5){ref-type="table"}\].

###### 

Correlation of lactate levels with predicted mortality by PIM 2 score in compliant and noncompliant groups
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In our study, we observed significantly high mortality among patients with high predicted mortality by PIM-2 score and high lactate levels despite absolute (100%) compliance with the sepsis bundle. Irrespective of compliance, blood lactate levels were significantly higher in nonsurvivor group as compared to the survivor group, both before and after the intervention, *P* \< 0.0001.

Phua *et al*., Samransamruajkit *et al*. and Rhodes *et al*. observed that adherence with 6-h sepsis bundle was significantly associated with a decrease in mortality which is dissimilar to our study.\[[@ref20][@ref21][@ref22]\] In the study by Phua *et al*., it was observed that compliance with individual elements of 6 h sepsis bundle was associated with decreased mortality.\[[@ref20]\] However, in contrast to our study, there was no significant difference in lactates (*P* = 0.17) among the survivor and nonsurvivor groups and Acute Physiology and Chronic Health Evaluation-II (APACHE-II) score was higher in the nonsurvivors (*P* \< 0.001) which may account for more severity and hence high mortality in the noncompliant group.

Samransamruajkit *et al*. and IMPress study by Rhodes *et al*.,\[[@ref21][@ref22]\] observed that compliance with sepsis bundle (70% and 36%, respectively) was associated with decreased mortality. A single study in pediatric age group by Samransamruajkit *et al*.,\[[@ref21]\] observed that implementation of sepsis bundle (two-time frames 2007--2009 and 2010--2011, before and after implementation of sepsis bundle) is associated with a reduction in mortality (*P* = 0.003) which is dissimilar to our study. In their study, there was not much difference in mortality prediction by PRISM-III score in pre- and post-sepsis bundle implementation whereas in our study the mortality was related to PIM-2 score mortality prediction and high lactates, irrespective of compliance. In IMPress study,\[[@ref22]\] the baseline lactates and illness severity scores, i.e., SOFA and APACHE-II were similar in both compliant and noncompliant groups, whereas in our study those who died had a higher baseline as well as postinterventional lactates and high predicted mortality by PIM-2 score.

Similar to our study, PeakeSL *et al*.,\[[@ref23]\] also observed in a randomized control trial including patients in early septic shock that 90-day mortality was 18.6% in the compliant group as compared to 18.8% in the noncompliant group (*P* = 0.90). There were also no significant differences in 28 days or in-hospital mortality, duration of organ support, or length of hospital stay. The authors postulated that it is possible that this reduced risk of death in noncompliant group may be because of low rates of chronic disease and better functional status, as evidenced by the low proportion of nursing home residents before randomization.

Coba *et al*.,\[[@ref24]\] observed that there was no significant difference in mortality among compliant and noncompliant groups after implementation of 6 h sepsis bundle (43.8% vs. 47.8%, *P* \> 0.05). This may be attributed to high severity of illness reflected by high baseline APACHE-II scores, SOFA scores, and predicted mortality (*P* \< 0.01) in the compliant group as compared to noncompliant group, which is similar to our study.

In our study, the blood lactate levels were also significantly higher in the compliant group as compared to the noncompliant group both before (6.97 ± 3.54 vs. 2.59 ± 2.39, *P* = 0.0001) and after intervention (3.34 ± 2.97 vs. 0.52 ± 0.33, *P* = 0.019) and high blood lactate levels were found to be significantly related to higher mortality which is similar to other studies.\[[@ref25][@ref26]\]

Despite a high compliance to 6 h sepsis bundle (77.59% patients fulfilling all the elements of sepsis bundle) in our study, mortality was not affected. This difference in findings may be attributed to the high predicted mortality at admission and high pre- and post-intervention lactates irrespective of compliance.

No consensus exists among clinicians regarding optimal hemodynamic monitoring and till date no method has been proven to be superior. Usual care, nowadays, includes early fluid resuscitation and antibiotic administration; certainly, this reflects the impact of broad-based implementation of SSC guidelines and bundles. If this continues to define "usual care," then perhaps it is no longer necessary to mandate specific protocols for resuscitation, as it appears that standard sepsis management has evolved to be consistent with published protocols.\[[@ref27]\]

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

In pediatric patients with severe sepsis and septic shock outcome is related to the severity of illness and lactate levels at the time of admission, irrespective of absolute adherence to 6 h sepsis bundle in our study.

The limitation of our study was that the noncompliant group had less number of patients so that the difference in the outcome of compliant versus noncompliant in different predicted mortality subgroups (PIM-2 score \<30%, 30%--50%, \>50%) failed to reach significance.

As ours is a tertiary level health-care center, we receive patients from peripheral units with high predicted mortality due to delay in timely referral so that it is difficult to evaluate the reduction in mortality by sepsis bundle which is most effective when applied in early hours of the evolution of sepsis.
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